Taking drug discovery towards cells and tissues - Register interest

This meeting is intended for industrial delegates.

Improving productivity, whilst increasing innovation, is a major challenge for the pharmaceutical sector. Attrition rates in drug discovery and development remain stubbornly high, with lack of efficacy being one of the major causes. Furthermore, drug discovery is changing, with the advent of new drug modalities, such as targeted protein degraders and modifiers, and more complex cellular targets, such as intrinsically-disordered proteins. Within this context, understanding underlying target biology, and the mechanisms of drug candidates in relevant disease contexts, is critical.

This one-day meeting at the Royal Society will explore how technological advances – in tomography, bioimaging and chemical biology – can take drug discovery towards cells and tissues. Such technologies have the potential throughout drug discovery pipelines – from target selection through to understanding the mechanisms of drug candidates - with the ultimate goal of driving effective translation.

Please note that registering your interest in the event does not guarantee you a ticket. All registrations will be reviewed by the Astbury Centre, and successful registrations will be invited to access official tickets. We will aim to contact you within 4 weeks of registration. For any queries relating to the event, please contact the Astbury Centre's Research and Innovation Officer Dr Adele Parry at [email protected]

Image credit: Dr Rene Frank - 3-dimensional molecular architecture of β-amyloid plaque.

Please note the agenda is provisional and may be updated nearer the time.

This event is not organised or endorsed by The Royal Society.

Event Venue & Nearby Stays

The Royal Society, 6-9 Carlton House Terrace, London, United Kingdom